Search Results - "NOMURA, Takako"

Refine Results
  1. 1

    Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis by Tadokoro, Tomoko, Tani, Joji, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Mimura, Shima, Fujita, Koji, Nomura, Takako, Morishita, Asahiro, Kobara, Hideki, Himoto, Takashi, Ono, Masafumi, Masaki, Tsutomu

    Published in Scientific reports (11-05-2024)
    “…Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on…”
    Get full text
    Journal Article
  2. 2

    Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C by Fujita, Koji, Oura, Kyoko, Yoneyama, Hirohito, Shi, Tingting, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Nomura, Takako, Morishita, Asahiro, Tsutsui, Kunihiko, Himoto, Takashi, Masaki, Tsutomu

    Published in Hepatology research (01-07-2019)
    “…Aim Albumin–bilirubin (ALBI) grade was investigated to predict prognosis of patients with cirrhosis. It was defined using the ALBI score calculated based on…”
    Get full text
    Journal Article
  3. 3

    Cancer Therapy Due to Apoptosis: Galectin-9 by Fujita, Koji, Iwama, Hisakazu, Oura, Kyoko, Tadokoro, Tomoko, Samukawa, Eri, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Morishita, Asahiro, Himoto, Takashi, Hirashima, Mitsuomi, Masaki, Tsutomu

    “…Dysregulation of apoptosis is a major hallmark in cancer biology that might equip tumors with a higher malignant potential and chemoresistance. The anti-cancer…”
    Get full text
    Journal Article
  4. 4

    Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients by Tadokoro, Tomoko, Nomura, Takako, Fujita, Koji, Manabe, Takushi, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Mimura, Shima, Tani, Joji, Morishita, Asahiro, Kobara, Hideki, Ono, Masafumi, Masaki, Tsutomu

    Published in BMC gastroenterology (01-04-2024)
    “…Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Correlation between serum galectin‐9 levels and liver fibrosis by Fujita, Koji, Niki, Toshiro, Nomura, Takako, Oura, Kyoko, Tadokoro, Tomoko, Sakamoto, Teppei, Tani, Joji, Yoneyama, Hirohito, Morishita, Asahiro, Kuroda, Noriyuki, Arai, Takeshi, Nishimoto, Naoki, Himoto, Takashi, Hirashima, Mitsuomi, Masaki, Tsutomu

    Published in Journal of gastroenterology and hepatology (01-02-2018)
    “…Background and Aim Chronic liver diseases progress from chronic inflammation to fibrosis to tumorigenesis. Galectin‐9, a β‐galactoside‐specific animal lectin,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Clinical efficacy of free androgen index, a surrogate hallmark of circulating free testosterone level, in male patients with HCV-related chronic liver disease by Himoto, Takashi, Fujita, Koji, Sakamoto, Teppei, Nomura, Takako, Morishita, Asahiro, Yoneyama, Hirohito, Haba, Reiji, Masaki, Tsutomu

    “…The role of free testosterone, that not bound to sex hormone-binding globulin, in male patients with HCV infection remains uncertain. We investigated whether…”
    Get full text
    Journal Article
  12. 12

    Galectin-9: An anticancer molecule for gallbladder carcinoma by TADOKORO, TOMOKO, MORISHITA, ASAHIRO, FUJIHARA, SHINTARO, IWAMA, HISAKAZU, NIKI, TOSHIRO, FUJITA, KOJI, AKASHI, EMIKO, MIMURA, SHIMA, OURA, KYOKO, SAKAMOTO, TEPPEI, NOMURA, TAKAKO, TANI, JOJI, MIYOSHI, HISAAKI, YONEYAMA, HIROHITO, HIMOTO, TAKASHI, HIRASHIMA, MITSUOMI, MASAKI, TSUTOMU

    Published in International journal of oncology (01-03-2016)
    “…Gallbladder cancer (GBC) is the most common and aggressive type of biliary tract cancer. There are various histological types of GBC, and the vast majority of…”
    Get full text
    Journal Article
  13. 13

    Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV by Tadokoro, Tomoko, Morishita, Asahiro, Fujita, Koji, Oura, Kyoko, Sakamoto, Teppei, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Masaki, Tsutomu

    Published in Internal Medicine (01-01-2018)
    “…Combination therapy with ledipasvir and sofosbuvir (LDV/SOF), direct-acting antiviral agents, is highly effective against hepatitis C virus genotype 1…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Antitumor effect of metformin in esophageal cancer: In vitro study by KOBAYASHI, MITSUYOSHI, KATO, KIYOHITO, IWAMA, HISAKAZU, FUJIHARA, SHINTARO, NISHIYAMA, NORIKO, MIMURA, SHIMA, TOYOTA, YUKA, NOMURA, TAKAKO, NOMURA, KEI, TANI, JOJI, MIYOSHI, HISAAKI, KOBARA, HIDEKI, MORI, HIROHITO, MURAO, KOJI, MASAKI, TSUTOMU

    Published in International journal of oncology (01-02-2013)
    “…Recent studies suggest that metformin, which is a member of the biguanide family and commonly used as an oral anti-hyperglycemic agent, may reduce cancer risk…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Association between microRNA-527 and glypican-3 in hepatocellular carcinoma by Nomura, Kei, Kitanaka, Akira, Iwama, Hisakazu, Tani, Joji, Nomura, Takako, Nakahara, Mai, Ohura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Mimura, Shima, Yoneyama, Hirohito, Kobara, Hideki, Morishita, Asahiro, Okano, Keiichi, Suzuki, Yasuyuki, Tsutsi, Kunihiko, Himoto, Takashi, Masaki, Tsutomu

    Published in Oncology letters (01-03-2021)
    “…The present study aimed to identify the specific microRNAs (miRNAs/miRs) and their corresponding target genes involved in hepatocellular carcinomas (HCCs)…”
    Get full text
    Journal Article
  19. 19
  20. 20